BG20578A3 - - Google Patents

Info

Publication number
BG20578A3
BG20578A3 BG18894A BG1889470A BG20578A3 BG 20578 A3 BG20578 A3 BG 20578A3 BG 18894 A BG18894 A BG 18894A BG 1889470 A BG1889470 A BG 1889470A BG 20578 A3 BG20578 A3 BG 20578A3
Authority
BG
Bulgaria
Application number
BG18894A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691943903 external-priority patent/DE1943903B2/de
Priority claimed from DE1943901A external-priority patent/DE1943901C3/de
Application filed filed Critical
Publication of BG20578A3 publication Critical patent/BG20578A3/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J19/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG18894A 1969-08-29 1970-08-20 BG20578A3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19691943903 DE1943903B2 (de) 1969-08-29 1969-08-29 Verfahren zur Herstellung von Cardenolid- und Bufadienolid-3- [2'J' didesoxy-2'3-oxidoglykosiden], sowie Cxtivao&a-^rß' -didesoxy-2'3' -oxido-glykoside]
DE1943901A DE1943901C3 (de) 1969-08-29 1969-08-29 Cardenolid-3-[2', 3' - didesoxyglykoside] und Verfahren zu ihrer Herstellung, sowie Verwendung dieser Verbindungen zur Bekämpfung von Herzkrankheiten

Publications (1)

Publication Number Publication Date
BG20578A3 true BG20578A3 (es) 1975-12-05

Family

ID=25757845

Family Applications (2)

Application Number Title Priority Date Filing Date
BG15518A BG18864A3 (es) 1969-08-29 1970-08-20
BG18894A BG20578A3 (es) 1969-08-29 1970-08-20

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG15518A BG18864A3 (es) 1969-08-29 1970-08-20

Country Status (16)

Country Link
US (1) US3838146A (es)
JP (2) JPS5248983B1 (es)
BE (1) BE755537A (es)
BG (2) BG18864A3 (es)
CA (1) CA923491A (es)
CH (2) CH537377A (es)
DK (2) DK128738B (es)
ES (1) ES383115A1 (es)
FI (1) FI49161C (es)
FR (1) FR2068530B1 (es)
GB (1) GB1323775A (es)
IL (1) IL35113A (es)
NL (1) NL7012422A (es)
OA (1) OA03653A (es)
PL (1) PL80915B1 (es)
SE (2) SE368570B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2237144A1 (de) * 1972-07-28 1974-02-14 Hoechst Ag Herzwirksame anhydrotalomethyloside und verfahren zu ihrer herstellung
DE2254060A1 (de) * 1972-11-04 1974-05-16 Hoechst Ag Cardenolid-3-eckige klammer auf 4'-amino-2',3',4'-tridesoxy-glykoside eckige klammer zu und verfahren zu ihrer herstellung
DE2256912C2 (de) * 1972-11-20 1984-04-05 Hoechst Ag, 6230 Frankfurt Digoxigenin-3-[2',3'-didesoxy-glykoside], Verfahren zu ihrer Herstellung und deren Verwendung
US5496806A (en) * 1990-01-23 1996-03-05 R. Erich Klemke Glycoside compounds and production and use thereof
CN103328038A (zh) 2010-12-01 2013-09-25 史拜诺莫度雷森公司 向神经解剖结构直接递送药剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1768164A1 (de) * 1968-04-06 1971-10-14 Hoechst Ag Tridesoxypyranoside und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
JPS538697B1 (es) 1978-03-31
DK127421B (da) 1973-11-05
FI49161C (fi) 1975-04-10
FR2068530B1 (es) 1973-08-10
OA03653A (fr) 1971-12-24
SE383521B (sv) 1976-03-15
FR2068530A1 (es) 1971-08-27
IL35113A (en) 1975-06-25
NL7012422A (es) 1971-03-02
BG18864A3 (es) 1975-03-20
CH537377A (de) 1973-07-13
GB1323775A (en) 1973-07-18
IL35113A0 (en) 1970-10-30
BE755537A (fr) 1971-03-01
CA923491A (en) 1973-03-27
CH537375A (de) 1973-05-31
PL80915B1 (es) 1975-08-30
DK128738B (da) 1974-06-24
US3838146A (en) 1974-09-24
SE368570B (es) 1974-07-08
JPS5248983B1 (es) 1977-12-14
FI49161B (es) 1974-12-31
ES383115A1 (es) 1972-12-16

Similar Documents

Publication Publication Date Title
AU465413B2 (es)
FR2034460B1 (es)
FI49161B (es)
AU470301B1 (es)
AU5113869A (es)
AU470661B1 (es)
AU5133369A (es)
AU4949169A (es)
CS151562B2 (es)
AU5077469A (es)
AU5079269A (es)
AU4923469A (es)
AU5109569A (es)
CS149305B1 (es)
FR2034452A1 (es)
AU5228269A (es)
BE737700A (es)
AU4953367A (es)
BE744957A (es)
BE743952A (es)
CH295669A4 (es)
BE741357A (es)
BE740190A (es)
BE739950A (es)
BE737938A (es)